Carisma Therapeutics has gone public, entered a broad collaboration with Moderna, and ceased development of its original ...

We live in a time of hope for millions around the world, as technological advancements and research breakthroughs hold the ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

Biopharmaceutical companies must address the frictions and challenges that have quietly infiltrated the drug development ...

ISCT and Kiji's Miguel Forte, M.D., is a tireless pioneer and advocate for advanced therapeutics whose career includes Big Pharma executive, regulator, board member, and biotech founder. Listen now to ...

The rapid adoption of AI in the pharmaceutical market has led to a revolution in the research process and pharmaceutical development techniques. The AI revolution is not free of risks, however. This ...

Google’s global market leader for life sciences, Shweta Maniar, spoke with Life Science Leader about how large and small biopharmaceutical companies are using AI to lower costs and expedite timelines.

AbZelectPRO™, a novel cell line development platform, is poised to revolutionize the production of biologics, including monoclonal antibodies (MAbs), bispecifics, trispecifics, Fc fusions, and other ...

In August 2023, Gut, a journal published by BMJ, released a study of over 24,000 patients with Parkinson’s disease, finding that certain gastrointestinal disorders — such as difficulty swallowing, ...